\
&
Contact us
\
&
Contact us
This was 7 years ago
LocationBrussels
Palace of Academies
Auditorium Albert II
Hertogstraat / Rue Ducale 1, 1000 Brussels
NCP Flanders organised in collaboration with the other Belgian National Contact Points at BELSPO and F.R.S.-FNRS an info session on the 2017/8 call for ERC Starting, Advanced and Synergy grants.
The info session was organised to support researchers with the preparation of their application for an ERC Starting, Advanced and Synergy grant.
Presentations
In the afternoon NCP Flanders organised a proposal writing workshop for Starting grants in collaboration with Yellow Research.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
